Data / Form D filings / OT Pharma Fund IX, LLC
OT Pharma Fund IX, LLC: Form D filing
OT Pharma Fund IX, LLC, a company in Boston, MD, filed a Form D with the SEC in 2025. The latest, on January 3, 2025, reports $3.4 million sold of an offering with no set size to 100 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 131 DARTMOUTH STREET, FLOOR 3, SUITE 24, Boston, MD, 02116
- Phone
- (617) 459-6208
- Industry
- Other
- Entity type
- Limited Liability Company
- Incorporated in
- Maryland
- Year incorporated
- 2024
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2049842
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | New notice | Indefinite | $3,371,529 | 100 | Nov 26, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nichola Eliovits | Executive Officer |
Other companies in Maryland that filed recently
- Hirostar USA, Inc. $1.2 million · Oct 27, 2026
- Hop Flyt, Inc. $1.5 million · Oct 14, 2026
- C&R Auto Inc. offering · Oct 13, 2026
- JBS Touring LLC $2.9 million · Sep 22, 2026
- Throne Labs, Inc. $14.1 million · Sep 17, 2026
- LeanOnWe Care, Inc. $500,010 · Sep 10, 2026
Every Form D from the week of Dec 30, 2024 · All recent filings in Maryland · All recent Other filings
Read from SEC EDGAR. Amount sold is what OT Pharma Fund IX, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.